Resources

The following resources from Digital Square at PATH and our partners focus on digital health innovation, digital transformation of health systems, and global goods for health.

The Digital Health Applied Leadership Program (DHALP) launched in 2021 as a learning program that enhances participants’ capacity to successfully lead and execute digital health programs.Designed with a comprehensive leadership curriculum for a diverse cohort of learners, the DHALP consists of core online courses, workshops, instruction from tutors, and guidance from country-specific coaches. These coaches support participants in planning and delivering a country team project designed to build digital health capacity across participating countries.The concept of the DHALP was co-created at the November 2019 Digital Health Leadership Capacity Building Conference by representatives from 17 low- and middle-income country governments, the World Health Organization (WHO), investors, and educators. With Digital Square’s support, the University of Global Health Equity (UGHE) is currently implementing the DHALP for Africa-based participants with a consortium that includes the University of Thies, the Stanford Center for Health Education, and Inshuti Mu Buzima-Partners in Health. Other partners include the World Bank and TechChange.

To achieve sustainability in digital health, we need a shared understanding of market forces and their influence on the digital health sector.Market forces have a role in determining:Which digital health tools get introduced, adopted, and scaled.The underlying costs of digital tools.The long-term opportunities for financing the digital transformation of health systems.Through a series of analyses, PATH Digital Square, Vital Wave, and a consortium of partners whose publications are featured here have identified current challenges to sustainability, outlined cost drivers for digital health software, and developed recommendations, tools, and models that can lead to a more sustainable digital health marketplace.

This slide provides a snapshot of the Group B Streptococcus (GBS) vaccine technology landscape, in the effort to track the development of GBS vaccine candidates and provide a summary of the various vaccine approaches being worked on around the world.This snapshot pairs with the GBS Vaccine Clinical Trial Tracker, which provides publicly available information on clinical trials of GBS vaccine candidates intended for disease prevention.To share any updates or corrections to the snapshot, please contact gbssnapshot@path.org.

This spreadsheet provides publicly available information on clinical trials of Group B Streptococcus (GBS) candidate vaccines intended for disease prevention.Sources of information for these trials include clinicaltrials.gov, who.int/clinical-trials-registry-platform, clinicaltrialsregister.eu, chictr.org.cn, and anzctr.org.au.Some information is also obtained through contact with investigators, sponsors, and funders of vaccine clinical trials. This spreadsheet pairs with the GBS Vaccine Snapshot, which provides a summary of the GBS vaccine candidates in development worldwide.To share any updates or corrections to the tracker, please contact gbssnapshot@path.org.